A large pipeline looks reassuring on a dashboard. It suggests demand, momentum, and future revenue.
But pipeline size is only the sum of the amounts entered into opportunity records. It does not tell you whether the right deals are present, whether buyers are progressing, or whether close dates are credible.
A pipeline can be large and dangerously weak at the same time.
When leaders distrust the forecast, the common response is to demand more pipeline. Teams may be told to maintain a multiple of quota—sometimes 10X—on the assumption that volume will compensate for low conversion.
That math can conceal the real problem. A 10X coverage target implies that roughly one dollar closes for every ten dollars entered. By contrast, a pipeline converting near 30 percent might require closer to 3X coverage. These are illustrations, not universal benchmarks; the right ratio depends on the company’s cycle, mix, and historical conversion.
The management question is not “How big is the pipeline?” It is “What quality of evidence sits behind the number?”
Weak pipelines accumulate records that should never have become opportunities. A friendly conversation becomes a deal. A proposal without a buying process receives a close date. A silent account remains open because removing it would reduce coverage.
The result is Pipeline Fiction: a large number built from seller expectation rather than buyer movement.
Adding more records increases noise. It also consumes selling time, distorts resource decisions, and makes the forecast harder to interpret.
In Zero-Point Selling™, the customer journey is Target → Suspect → Lead → Opportunity → Customer. A record earns movement only when defined evidence is present.
An Opportunity is not simply an account a salesperson wants to win. It requires fit, a relevant business problem, meaningful buying intent, and an agreed next step appropriate to the sale.
Pipeline health therefore depends on questions such as:
These questions turn the pipeline from a collection of opinions into an operating view of buyer progress.
Suppose two teams each report $3 million in pipeline.
Team A has dozens of open opportunities, many without recent buyer contact, defined problems, or scheduled next steps. Close dates move every month.
Team B has fewer opportunities. Each has documented evidence, a clear owner, a dated next action, and stage-specific exit criteria. Some deals are disqualified quickly.
The totals may match, but the pipelines are not equally healthy. Team B has less fiction and more decision value.
Coverage still matters. But it should be interpreted alongside conversion, velocity, aging, stage distribution, and evidence quality.
Leaders do not need a bigger collection of hopeful records. They need a pipeline that helps them decide where to invest attention, where to intervene, and what revenue is genuinely possible.
That requires one customer journey, shared stage definitions, Minimum Necessary Information, and a CRM that functions as operating memory.
Pipeline size is a quantity. Pipeline health is a management capability.
See whether your pipeline reflects buyer progress—or whether stage ambiguity and stale records are creating false confidence.
Take the Revenue Operating System Assessment.
